NSRX
Nasus Pharma LtdCompany with tickers: NSRX
CIK
2029039
Shares Outstanding
11,710,808
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-31 | Teleman Dan Benjamin | Director, Chief Executive Officer | Buy | 15,000 |
| 2026-03-18 | Silberman David | Director | Other | 0 |
| 2026-03-18 | Teleman Dan Benjamin | Director, Chief Executive Officer | Other | 0 |
| 2026-03-18 | Teleman Dan Benjamin | Director, Chief Executive Officer | Other | 6,246 |
| 2026-03-18 | Hershman Ronnie | Director | Other | 0 |
| 2026-03-18 | Hershman Ronnie | Director | Other | 909,156 |
| 2026-03-18 | Hershman Ronnie | Director | Other | 0 |
| 2026-03-18 | Megiddo Dalia | Director, Chief Development Officer | Other | 1,888,873 |
| 2026-03-18 | Gilboa Udi | Insider | Other | 0 |
| 2026-03-18 | Gilboa Udi | Insider | Other | 1,919,281 |
| 2026-03-18 | Rubin Eyal | Chief Financial Officer | Other | 0 |
| 2026-03-18 | Shacham Sharon | Director | Other | 0 |
| 2026-03-18 | Israel Isaac | Director | Other | 0 |